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[~  Managing community exercise referrals: does cross infection 
occur? 
D. Riley, R. McVean, H. Langman, A. Orr, A.M. Jones, A.K. Webb, M.E. Dodd. 
Manchester Adult Cystic Fibrosis Centre (MACFC), South Manchester University 
Hospitals' NHS Trust, Manchester, UK 
Introduction: We have previously reported the controversies of exercise referral 
to community gyms and the risks of cross infection for patients with different 
microbiological groups (MG) [1]. As per MACFU guidelines each individual is 
informed if another patient attends the same gym and specific attendance times 
arranged to avoid direct contact. The aim of the study was to determine if cross 
infection occurred between patients with different MG referred to the same gym. 
Methods: We surveyed the records of 41 referrals made over a 3 year period (2003 
2005). Data was collected for MG and groups of patients attending the same gym. 
Attendance ratings and changes to microbiological grouping including strain typing 
were recorded. 
Results: 23 females and 18 males were referred. Mean (range) BMI 22.4 (14 38.3), 
FEV1 2.38 (0.85 4.4)l/rain. The MG consisted of 16 sporadic Pseudomonas 
aeruginosa (Pa), 13 transmissible Pa, 9 non-Pa, 2 Burkholderia cenocepacia, nd 
1 Burkholderia gladioli. 
Three pairs (6 patients), mean (range) BMI 21.95 (19.4 29.2) FEV12.3 (1.65 3.3) 
were referred with different MG's to 3 different venues. Pair 1: sporadic Pa and 
transmissible Pa. Pair 2: non-Pa and transmissible Pa; and pair 3: non-Pa and 
sporadic Pa. 5 of the 6 were classed as regular attenders (>1 visit per week) and 
1 a poor attender. All patients reported lapses in attendance r lated to ill health or 
busy social/work spells for periods up to 2 months. None of the pairs attending 
the same venue changed microbiological group as a result of attendance at their 
exercise facility. 
Conclusion: Routine microbiological surveillance and negotiation of attendance 
times have prevented cross infection in patients with different MG's attending the 
same gym. 
References 
[1] McVean 2004. 
[~  Community physiotherapy for newly diagnosed infants with 
Cystic Fibrosis (newborn screening) 
R.D. McAleer. Royal District Nursing Service Cystic Fibrosis Home Support Team, 
Melbourne, Australia 
The Victorian Royal District Nursing Service Cystic Fibrosis Home Support Team 
was established in 1989 in conjunction with the introduction of newborn screening. 
The community team consists of one cardiothoracic senior clinician physiotherapist 
and two CF clinical nurse consultants that service Metropolitan Melbourne and 
the Mornington Peninsula (approximately 80km radius). Community physiotherapy 
support and education for parents and family members of newly diagnosed infants 
with CF, is provided to those from either the Royal Children's Hospital or Monash 
Medical Centre CF units. 
The community physiotherapy role provides a communicative link between the 
family and the hospital-based physiotherapy and medical teams. Ongoing education 
regarding CF, physiotherapy techniques, acute assessment, compliance and motiva- 
tion, and the referral to relevant CF team members as appropriate, plays a vital role 
in the success of the RDNS CF team. 
An audit of newly diagnosed infants with CF was undertaken toevaluate the degree 
of community physiotherapy input that had occurred from August 2003 to mid- 
April 2005. Fifteen infants had been registered by RDNS, with a total of 96 home 
physiotherapy visits, consisting of 103.5 hours of physiotherapy input. The greatest 
amount of visits to one infant was 22, with the least amount of visits being 2. 
Concentrated community physiotherapy support is not only a valuable asset for 
the hospital-based CF teams, but advantageous for the newly diagnosed infant and 
family. 
9. Physiotherapy 
I~]A  comparison of five airway clearance techniques in the 
treatment of people with Cystic Fibrosis 
J.A. Pryor 1 , E. Tannenbaum 2, D. Cramer 3, S.F. Scott 1, J. Burgess 1 , K. Gyi 1 , 
M.E. Hodson 1. 1Department of Cystic Fibrosis, Royal Brompton Hospital, 
2Department of Physiotherapy, Great Ormond Street Hospital for Children; 
3Department of Lung Function, Royal Brompton HosTital, London, UK 
Aim: To compare the long-term effects, over one year, of the airway clearance 
techniques of the active cycle of breathing techniques, autogenic drainage, cornet, 
flutter and positive xpiratory pressure using the primary outcome measure of forced 
expiratory volume in one second (FEV1). 
Method: Seventy-five subjects were randomised toone of the five airway clearance 
regimens, in the sitting position, and monitored at monthly intervals for one year. 
Measurements included FEV1, forced vital capacity (FVC), maximal expiratory 
flow at 25% of forced vital capacity (MEF25), residual volume as a percentage 
of total lung capacity (RV/TLC%), body mass index, exercise capacity (modified 
shuttle test) and health related quality of life (Chronic Respiratory Questionnaire 
and Short Form-36). The mixed model analysis of variance was used to analyse the 
data. 
Results: Median age: 27 years (range:17 63 years). Forty-seven were male. Using 
intention to treat, lung function data were available on 65 subjects. There were no 
statistically significant differences among the regimens in the primary outcome 
measure of FEV1 (p 0.35). There was a significant deterioration over time 
(p 0.02) for the group as a whole. There were no statistically significant differences 
among the regimens in the secondary outcome measures. 
Conclusions: This study suggests that there are no significant differences among 
the airway clearance regimens of the active cycle of breathing techniques, autogenic 
drainage, cornet, flutter or positive expiratory pressure over the period of one year. 
Greater consideration should therefore be given to patient choice. 
• Establishing paediatric patients on an Adaptive Aerosol 
Delivery (AAD) device 
R McCormack, A. McDonald, K.W Southern. Regional Paediatric CF Centre, 
Royal Liverpool Children ~' HosTital, Liverpool, UK 
Aerosol drug delivery is a major component of CF care and requires ignificant time 
and resources. We describe the transfer of children from a standard jet nebuliser 
system (with venturi effect) to an adaptive aerosol delivery (AAD) device and the 
particular issues raised by this change in practice. In the UK, an AAD device (I-neb) 
is made available to patients free of charge if they are prescribed a specific brand of 
Colistin (Promixin). The I-neb uses a vibrating mesh plate with multiple apertures 
to aerosolise liquid. During the first three breaths the AAD device analyses pressure 
changes relating to airflow establishing the optimum time for aerosol delivery during 
inspiration. Once the pre-programmed dose is delivered the device gives audio 
and visual feedback informing the patient hat treatment is complete. Unpublished 
data from the company suggest more efficient drug delivery resulting in reduced 
dosage. Training of correct breathing technique to include a prolonged inspiratory 
phase can significantly reduce treatment time. This can be facilitated by a software- 
training package. Since March 2005, 52 patients have been established on the 
I-neb (age range 2 17 years). In 20 children, treatment times ranged from 2 to 
6 minutes (recorded by in-device data logger). In addition to shorter treatment 
times, patients commented positively on portability and quieter operation. With 
improving technology CF clinics are faced with an increasing choice of devices to 
deliver therapies (often with a lack of clinical trial data). In our experience, despite 
the time and resource implication in changing to an AAD device, our families 
have provided positive feedback in all cases. More information is needed regarding 
dosage. 
